CTS e-Learning Modules 2020-04-22T21:49:24+00:00

CTS e-Learning Modules

COPD PHARMACOTHERAPY UPDATENEW

This one-hour accredited program (Section 1) provides updated evidence-based recommendations from the CTS Clinical Practice Guideline on Pharmacotherapy in patients with COPD – 2019 Update of Evidence. This case-based program summarizes important pharmacotherapy recommendations and provide a step-by-step approach to guide treatment choices in clinical practice. Specifically, the program addresses how a clinician chooses appropriate maintenance pharmacotherapies in patients with stable COPD to reduce symptom burden, notably dyspnea and exercise intolerance, and reduce the risk of future acute exacerbations of COPD (AECOPD).

 

Developed by Drs. Mohit Bhutani, Jean Bourbeau, Paul Hernandez and Darcy Marciniuk, the program is directed to respirologists, family physicians, medical trainees, respiratory therapists, physical therapists, nurses, pharmacists, and other health professionals working in COPD. After completion of this program, participants will be able to:

  • Summarize the recent updates in the new CTS Clinical Practice Guideline on Pharmacotherapy in patients with COPD – 2019 Update of Evidence;
  • Integrate recommendations for maintenance pharmacotherapy to improve symptoms, quality of life and reduce the risk of acute exacerbations of COPD (AECOPD); and
  • Demonstrate a practical Canadian approach and pharmacotherapy recommendations for optimizing management and outcomes for COPD patients*

You can access the course at: Pharmacotherapy in Patients with COPD – 2019 Update of Evidence

This program was developed in collaboration with MDBriefCase and supported by an Independent Medical Education grant from GSK.

*Refer to additional CTS guidance on managing COPD during COVID-19 at https://cts-sct.ca/covid-19/


RECOGNITION AND MANAGEMENT OF SEVERE ASTHMA

This one-hour accredited program (Section 1) is based on the 2017 Recognition and Management of Severe Asthma: Canadian Thoracic Society Position Statement and is directed to health practitioners who diagnose, treat, and manage adults and children with severe asthma.

Developed by Drs. Catherine Lemiere, Diane Lougheed and Connie Yang, the program features two cases, one adult and one pediatric, woven throughout that highlight key learning points.

After completion of the program, the participant will be able to:

  • Distinguish between severe asthma and uncontrolled but not severe asthma;
  • Describe how biomarkers may be used to identify responders to newer treatment options;
  • Discuss the evidence and safety of newer treatment options for individuals with severe asthma.

You can access the course at: Recognition and Management of Severe Asthma.

This program was developed in collaboration with MDBriefCase and supported by an Independent Medical Education grant from GSK.